Physician profile
Tzuting A Stevens
NPI 1194250514
$1,422.31
in general payments reported to CMS, 2019-2025
5 companies · $1,334 in 2025
The $1,334 reported for 2025 was more than what 91% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $32.27 · 2024: $55.90 · 2025: $1,334.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $866 · Food and Beverage: $557.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $865.76 |
| Food and Beverage | $556.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mimedx Group, INC. | $1,295.43 | 2025 | |
| Kerecis Limited | $38.71 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Solventum Corporation | $33.56 | 2024 | Activ.A.C. |
| Kci USA, INC. | $32.27 | 2023 | Promogran Prisma, V.A.C. Dermatac, 3m Cavilon |
| Urgo Medical North America, LLC | $22.34 | 2024 | Urgoclean Ag |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tzuting Stevens listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.